Latest DEF 14A proxy statements

Dogwood Therapeutics, Inc. calls a special meeting to approve the conversion of non-voting preferred stock into common stock, significantly diluting existing shareholders, and to expand its equity incentive plan.

Moderna, Inc. has filed its definitive proxy statement with the SEC, an administrative step for shareholder meetings.

Sandisk Corp. has filed definitive additional soliciting materials with the U.S. Securities and Exchange Commission.

ImmunityBio, Inc. has increased its authorized common stock to 1.65 billion shares to secure future funding and meet existing commitments.

Verint Systems Inc. stockholders are invited to a special meeting on November 18, 2025, to vote on a proposed merger with Calabrio, Inc., an affiliate of Thoma Bravo, for $20.50 per share in cash.

ProFrac Holding Corp. will pay its annual $7 million shared services fee to related party Wilks Brothers in Class A Common Stock instead of cash to boost liquidity and meet debt covenants, following majority shareholder approval.

Innventure, Inc. is seeking stockholder approval for the potential issuance of common stock exceeding 20% to YA II PN, LTD. (Yorkville) under two convertible debenture agreements to fund working capital and operating expenses.

Future FinTech Group Inc. announced details for its 2025 Annual Shareholders Meeting, including key proposals for director elections, auditor ratification, an equity plan, and executive compensation.

SR Bancorp, Inc. announced its 2025 Annual Meeting of Stockholders to be held on November 19, 2025, to elect directors and ratify its independent accounting firm.

Future FinTech Group Inc. announces its 2025 Annual Meeting of Shareholders to vote on director elections, auditor ratification, a new equity plan, and executive compensation.

Richtech Robotics Inc. has increased its authorized Class B Common Stock by 400% and expanded its 2023 Stock Option Plan with an evergreen feature to enhance equity compensation.

Blaize Holdings, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 3, 2025, to vote on director elections, a corporate governance amendment, and auditor ratification.

Provident Financial Holdings, Inc. announced its 2025 Annual Meeting of Shareholders will be held virtually on November 20, 2025, to vote on director elections, executive compensation, and auditor ratification.

DT Cloud Star Acquisition Corporation has further adjourned its annual general meeting to October 22, 2025, allowing shareholders more time to vote or withdraw redemption requests.

SRx Health Solutions, Inc. has secured majority shareholder approval for significant capital raises, an increase in authorized shares, a reduction in shareholder meeting quorum, and an additional reverse stock split.

DSS, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation, while disclosing significant related party transactions and financial reserves.

The OLB Group, Inc. has increased its authorized common stock from 50 million to 1 billion shares via written consent from majority shareholders, aiming for greater financial and strategic flexibility.

The Marzetti Company announces its 2025 Annual Meeting of Shareholders, detailing director elections, executive compensation votes, and a new omnibus incentive plan.

Workhorse Group Inc. is actively soliciting shareholder votes to approve its merger with Motiv Power Systems, Inc., aiming to dominate the medium-duty EV market.

Workhorse Group Inc. and Motiv Power Systems, Inc. CEOs release a video encouraging shareholders to vote FOR the proposed merger at the upcoming Annual Meeting on November 12, 2025.

Workhorse Group Inc. announces a definitive merger agreement with Motiv Power Systems, Inc. to create a leading medium-duty electric truck company.

Ondas Holdings Inc. calls a special meeting to vote on doubling authorized common stock and significantly expanding its equity incentive plan.

STAAR Surgical Company announced preliminary net sales of $94.7 million for Q3 2025, a 6.9% increase year-over-year, driven by a significant China shipment payment and growth outside China, despite reduced new orders from Chinese distributors.

Xilio Therapeutics will hold a special meeting on November 21, 2025, to vote on repricing underwater employee stock options and approving a new 2025 Stock Incentive Plan to address significant dilution and retain talent.

Crexendo, Inc. announced its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification, while highlighting significant operational and financial achievements.

Nabors Energy Transition Corp. II extends its deadline to complete a business combination by one month to November 18, 2025, supported by a $250,000 loan from an affiliate.

TransCode Therapeutics, Inc. filed an amendment to its Form 8-K/A, clarifying the effective date and rights agent for its Contingent Value Rights Agreement, which outlines future payments to shareholders from asset monetization.

OS Therapies Incorporated adjourned its 2025 annual meeting to October 21, 2025, to solicit additional proxies, while also releasing an investor presentation detailing its clinical pipeline and strategic milestones.

Tesla urges shareholders to approve the 2025 CEO Performance Award for Elon Musk, citing its importance for retaining his leadership and achieving ambitious growth targets.

LAVA Therapeutics N.V. shareholders are invited to an Extraordinary General Meeting on November 7, 2025, to vote on XOMA Royalty Corporation's amended tender offer of $1.04 cash plus one Contingent Value Right per share.